Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic Is Not a Responsible Act

被引：0
|
作者：
Schreiber, Stefan [1 ,2 ]
Dignass, Axel [3 ]
Rogge, Annette [4 ]
Rubin, David T. [5 ,6 ]
机构：
[1] Univ Hosp Schleswig Holstein, Dept Internal Med 1, Kiel, Germany
[2] Univ Kiel, Excellence Cluster Precis Med Inflammat, Kiel, Germany
[3] Agaples Markus Hosp, Dept Med 1, Frankfurt, Germany
[4] Univ Hosp Schleswig Holstein, Inst Expt Med, Med Eth, Kiel, Germany
[5] Univ Chicago, Inflammatory Bowel Dis Ctr, Chicago, IL 60637 USA
[6] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷 / 12期
关键词：
Crohn disease; ulcerative colitis; drug development; registration trial; ethics; regulatory trials;
D O I：
10.1093/ecco-jcc/jjaa127
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The intense competition for resources to combat COVID-19 has greatly reduced access to health care for patients with other diseases. After the disastrous overrun of hospitals through COVID-19 patients in some jurisdictions, availability of resources for 'elective' medical procedures, including care for the chronically ill, has been greatly reduced in many places as a pre-emptive measure before or during the blooming of infection clusters. Pharmaceutical companies have either stopped recruitment or even cancelled ongoing clinical trials in chronic diseases. Pre-emptive triage and its impact on medical ethics is discussed in the framework of care for inflammatory bowel disease.
引用
收藏
页码：1765 / 1768
页数：4
相关论文
共 50 条
  • [1] Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic
    Reinisch, Walter
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S815 - S819
  • [2] Inflammatory bowel disease clinical service recovery during the COVID-19 pandemic
    Din, Shahida
    Gaya, Daniel
    Kammermeier, Jochen
    Lamb, Christopher A.
    Macdonald, Jonathan
    Moran, Gordon
    Parkes, Gareth
    Pollok, Richard
    Sebastian, Shaji
    Segal, Jonathan
    Selinger, Christian
    Smith, Philip J.
    Steed, Helen
    Arnott, Ian D.
    FRONTLINE GASTROENTEROLOGY, 2022, 13 (01) : 77 - 81
  • [3] Management of inflammatory bowel disease during the COVID-19 pandemic
    Hisamatsu, Tadakazu
    IMMUNOLOGICAL MEDICINE, 2022, 45 (03) : 128 - 135
  • [4] Management of inflammatory bowel disease during COVID-19 pandemic
    Ribaldone, Davide G.
    Astegiano, Marco
    Actis, Giovanni C.
    Pellicano, Rinaldo
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2020, 66 (03) : 184 - 186
  • [5] Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic
    Martinelli, Massimo
    Strisciuglio, Caterina
    Fedele, Flora
    Miele, Erasmo
    Staiano, Annamaria
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (09) : E95 - E96
  • [6] Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic
    Bhat, Shubha
    Farraye, Francis A.
    Moss, Alan C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (09): : 1532 - 1533
  • [7] Letter: inflammatory bowel disease services during the Covid-19 pandemic
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1063 - 1063
  • [8] Inflammatory bowel disease during the COVID-19 pandemic: manifestations and management
    Stallmach, Andreas
    Reuken, Philipp A.
    Grunert, Philip
    Teich, Niels
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (12): : 1795 - 1801
  • [9] Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
    Lin, Simeng
    Lau, Louis Hs
    Chanchlani, Neil
    Kennedy, Nicholas A.
    Ng, Siew C.
    GUT, 2022, 71 (07) : 1426 - 1439
  • [10] Clinical trials during COVID-19 pandemic
    不详
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (09): : E88 - E89
12345